Ambrosia Ventures is a strategic investment and advisory firm focused exclusively on the life sciences sector. We partner with biotech, medtech, and pharmaceutical companies at critical inflection points by evaluating acquisition opportunities, licensing deals, and strategic transactions across the full spectrum of therapeutic development and healthcare innovation.

Our principals bring deep transactional expertise across cross-border deals, platform asset evaluation, and corporate strategy, with an active deal pipeline spanning RNA therapeutics, dermatology, pharmaceutical manufacturing, and beyond. We engage selectively with companies where we can add meaningful strategic and transactional value.